|
|
 |
|
Viewing report
|
|
|
|
APP Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 27
APP Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Summary
APP Pharmaceuticals, Inc (APP) is a subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. It is engaged in developing, manufacturing and marketing injectable pharmaceutical products with a focus on injectable critical care, anti-infective and oncology markets. The company manufactures products in three basic forms namely liquid, powder and freeze-dried. The company markets number of products products in various levels of dosages and formulations. APP's products are used in the area of clinical care such as Cardiac Care, Dialysis, Oncology, Orthopedics, Pediatrics, Psychiatry and Radiology. The company markets its products in the US and Canada. It is headquartered in Illinois, the US.
APP Pharmaceuticals, Inc. Key Recent Developments…
Jun 15, 2011: APP Pharmaceuticals Invests $38m To Expand Manufacturing Facility At Grand Island, New York
Mar 25, 2011: APP Pharmaceuticals Issues Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
Mar 07, 2011: Fresenius Kabi Pharmaceuticals Files Form 25 To Delist And Deregister Contingent Value Rights For APP Pharmaceuticals
Feb 23, 2011: Fresenius Kabi Pharmaceuticals Files Form 10-K For APP Pharmaceuticals
Feb 15, 2011: Western New York Businesses Reduce Energy Costs By $2.4m Annually With NYSERDA Support
GlobalData’s APP Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Customers who bought this item also bought
Fresenius SE (FREG) - Financial and Strategic SWOT Analysis Review
Fresenius Kabi AG Market Share Analysis
Fresenius Medical Device Company Intelligence Report
Fresenius Medical Care AG & Co. KGaA Market Share Analysis
Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review
Angiotech Pharmaceuticals, Inc. (ANP) - Financial and Strategic SWOT Analysis Review
La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review
NetApp, Inc. (NTAP) - Financial and Strategic SWOT Analysis Review
Fresenius Medical Care AG & Co. KGaA (FME) - Financial and Strategic SWOT Analysis Review
Hollingsworth & Vose Company - Strategic SWOT Analysis Review
|
|
|
|
